Honorary Professor Josephine Forbes
Honorary Professor

Josephine Forbes

Email: 

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Qualifications

  • Bachelor, University of Melbourne
  • Doctor of Philosophy, University of Melbourne

Search Professor Josephine Forbes’s works on UQ eSpace

259 works between 1995 and 2025
All (259) Journal Article (183) Book Chapter (5) Conference Publication (71)

221 - 240 of 259 works

2004

Journal Article

Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy

Lee, Fiona T. H., Cao, Zemin, Long, David M., Panagiotopoulos, Sianna, Jerums, George, Cooper, Mark E. and Forbes, Josephine M. (2004). Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. Journal of the American Society of Nephrology, 15 (8), 2139-2151. doi: 10.1097/01.ASN.0000135055.61833.A8

Interactions between angiotensin II and NF-κB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy

2004

Journal Article

Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: role of advanced glycation end products

Lassila, Markus, Seah, Kwee K., Allen, Terri J., Thallas, Vicki, Thomas, Merlin C., Candido, Riccardo, Burns, Wendy C., Forbes, Josephine M., Calkin, Anna C., Cooper, Mark E. and Jandeleit-Dahm, Karin A. M. (2004). Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: role of advanced glycation end products. Journal of the American Society of Nephrology, 15 (8), 2125-2138. doi: 10.1097/01.ASN.0000133025.23732.46

Accelerated nephropathy in diabetic apolipoprotein E-knockout mouse: role of advanced glycation end products

2004

Journal Article

Advanced glycation end product-interventions reduce diabetes-accelerated atherosclerosis

Forbes, Josephine M., Yee, Louis Teo Loon, Thallas, Vicki, Lassila, Markus, Candido, Riccardo, Jandeleit-Dahm, Karin A., Thomas, Merlin C., Burns, Wendy C., Deemer, Elizabeth K., Thorpe, Susan M., Cooper, Mark E. and Allen, Terri J. (2004). Advanced glycation end product-interventions reduce diabetes-accelerated atherosclerosis. Diabetes, 53 (7), 1813-1823. doi: 10.2337/diabetes.53.7.1813

Advanced glycation end product-interventions reduce diabetes-accelerated atherosclerosis

2004

Journal Article

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats

Wigg, SJ, Tare, M, Forbes, J, Cooper, ME, Thomas, MC, Coleman, HA, Parkington, HC and O'Brien, RC (2004). Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. Diabetologia, 47 (6), 1038-1046. doi: 10.1007/s00125-004-1411-x

Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats

2004

Journal Article

Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy

Forbes, Josephine M., Thallas-Bonke, Vicki, Cooper, Mark E. and Thomas, Merlin C. (2004). Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy. Current Pharmaceutical Design, 10 (27), 3361-3372. doi: 10.2174/1381612043383151

Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy

2004

Journal Article

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat

Davis, B. J., Forbes, J. M., Thomas, M. C., Jerums, G., Burns, W. C., Kawachi, H., Allen, T. J. and Cooper, M. E. (2004). Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat. Diabetologia, 47 (1), 89-97. doi: 10.1007/s00125-003-1256-8

Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat

2004

Journal Article

Identification of angiotensin converting enzyme 2 in the rodent retina

Tikellis, C., Johnston, C. I., Forbes, J. M., Burns, W., Thomas, M. C., Lew, R. A., Yarski, M., Smith, A. I. and Cooper, M. E. (2004). Identification of angiotensin converting enzyme 2 in the rodent retina. Current Eye Research, 29 (6), 419-427. doi: 10.1080/02713680490517944

Identification of angiotensin converting enzyme 2 in the rodent retina

2003

Journal Article

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors

Rizkalla, Bizhoy, Forbes, Josephine M., Cooper, Mark E. and Cao, Zemin (2003). Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors. Journal of the American Society of Nephrology, 14 (12), 3061-3071. doi: 10.1097/01.ASN.0000099374.58607.C9

Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptors

2003

Journal Article

Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2

Osicka, Tanya M., Russo, Leileata M., Qiu, Mei-Lan, Brammar, Gail C., Thallas, Vicki, Forbes, Josephine M., Comper, Wayne D. and Jerums, George (2003). Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2. Journal of Hypertension, 21 (12), 2399-2407. doi: 10.1097/00004872-200312000-00029

Additive effects of hypertension and diabetes on renal cortical expression of PKC-α and -ε and α-tubulin but not PKC-β1 and -β2

2003

Conference Publication

Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.

Boner, G, Thallas, V, Cooper, ME, Rizkalla, B, Qui, ML and Forbes, JM (2003). Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.. 36th Annual Meeting of the American-Society-of-Nephrology, San Diego California, Nov 12-17, 2003. LIPPINCOTT WILLIAMS & WILKINS.

Interference with advanced glycation end-products (AGEs) attenuates extracellular matrix (ECM) accumulation in diabetic nephropathy via protein kinase C (PKC) dependent pathways.

2003

Journal Article

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease

Jerums, George, Panagiotopoulos, Sianna, Forbes, Josephine, Osicka, Tanya and Cooper, Mark (2003). Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Archives of Biochemistry And Biophysics, 419 (1), 55-62. doi: 10.1016/j.abb.2003.08.017

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease

2003

Conference Publication

Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711

Allen, TJ, Forbes, JM, Yee, LT, Thallas, V, Thomas, MC, Candido, R, Jandeleit-Dahm, KA and Cooper, ME (2003). Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711. 76th Annual Scientific Session of the American-Heart-Association, Orlando Florida, Nov 07-12, 2003. LIPPINCOTT WILLIAMS & WILKINS.

Attenuation of diabetes associated atherosclerosis with the advanced glycation end product cross-link breaker, ALT-711

2003

Journal Article

Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats

Osicka, Tanya M., Forbes, Josephine M., Thallas, Vicki, Brammar, Gail C., Jerums, George and Comper, Wayne D. (2003). Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats. Nephrology, 8 (4), 205-211. doi: 10.1046/j.1440-1797.2003.00159.x

Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats

2003

Journal Article

Role of advanced glycation end products in diabetic nephropathy

Forbes, Josephine M., Cooper, Mark E., Oldfield, Matthew D. and Thomas, Merlin C. (2003). Role of advanced glycation end products in diabetic nephropathy. Journal of the American Society of Nephrology, 14 (suppl 3), S254-S258. doi: 10.1097/01.ASN.0000077413.41276.17

Role of advanced glycation end products in diabetic nephropathy

2003

Journal Article

Reduced tubular cation transport in diabetes: prevented by ACE inhibition

Thomas, Merlin C., Tikellis, Chris, Burns, Wendy C., Thallas, Vicki, Forbes, Josephine M., Cao, Zemin, Osicka, Tanya M., Russo, Leileata M., Jerums, George, Ghabrial, Hany, Cooper, Mark E. and Kantharidis, Phillip (2003). Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney International, 63 (6), 2152-2161. doi: 10.1046/j.1523-1755.2003.00006.x

Reduced tubular cation transport in diabetes: prevented by ACE inhibition

2003

Journal Article

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

Candido, Riccardo, Forbes, Josephine M., Thomas, Merlin C., Thallas, Vicki, Dean, Rachael G., Burns, Wendy C., Tikellis, Christos, Ritchie, Rebecca H., Twigg, Stephen M., Cooper, Mark E. and Burrell, Louise M. (2003). A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circulation Research, 92 (7), 785-792. doi: 10.1161/01.RES.0000065620.39919.20

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

2003

Journal Article

Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy

Tikellis, Christos, Johnston, Colin I., Forbes, Josephine M., Burns, Wendy C., Burrell, Louise M., Risvanis, John and Cooper, Mark E. (2003). Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy. Hypertension, 41 (3), 392-397. doi: 10.1161/01.HYP.0000060689.38912.CB

Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy

2003

Journal Article

Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization

Clavant, Steven P., Forbes, Josephine M., Thallas, Vicki, Osicka, Tanya M., Jerums, George and Comper, Wayne D. (2003). Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization. Nephron, 93 (2), 51-60. doi: 10.1159/000068528

Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization

2003

Journal Article

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes

Forbes, Josephine M, Thallas, Vicki, Thomas, Merlin C, Founds, Hank W, Burns, Wendy C, Jerums, George and Cooper, Mark E (2003). The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 17 (12), 1762-1764.

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes

2002

Journal Article

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

Twigg, Stephen M., Cao, Zemin, McLennan, Sue V., Burns, Wendy C., Brammar, Gail, Forbes, Josephine M. and Cooper, Mark E. (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology, 143 (12), 4907-4915. doi: 10.1210/en.2002-220619

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

Current funding

  • 2024 - 2026
    Understanding RAGE Expression and Function in Human T and Dendritic Cells to Refine the Use of RAGE Targeting Therapeutics for Type 1 Diabetes Prevention
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2022 - 2026
    Designing and translating novel therapies for diabetes and kidney disease
    NHMRC Investigator Grants
    Open grant

Past funding

  • 2021 - 2024
    Innovative delivery methods for the biologic soluble RAGE to prevent Type 1 Diabetes
    JDRF Pilot and Innovation Awards
    Open grant
  • 2019 - 2021
    RAGE as a novel therapeutic target for T1D
    Juvenile Diabetes Research Foundation - International
    Open grant
  • 2019
    Dissolution DNP Hyperpolariser
    UQ Research Facilities Infrastructure Grants
    Open grant
  • 2019 - 2021
    Preventing progression of diabetic kidney disease by targeting mitochondrial function
    NHMRC Project Grant
    Open grant
  • 2016 - 2017
    Genetic susceptibility to mitochondrial dysfunction as a risk factor for diabetic nephropathy (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2016 - 2018
    Advanced Glycation in the development of T1D (Helmsley Charitable Trust - George Eisenbath nPOD award for team science) - Administered by the University of Miami
    University of Miami
    Open grant
  • 2016 - 2020
    Investigating pathways to alleviate the burden of diabetes and kidney disease
    NHMRC Research Fellowship
    Open grant
  • 2016
    Mitochondrial dysfunction as a mediator of diabetic kidney disease
    Diabetes Australia Research Program
    Open grant
  • 2015 - 2018
    Environmental Determinants of Islet Autoimmunity (ENDIA) (University of Adelaide led JDRF Australian Type 1 Diabetes Clinical Research Network (T1DCRN) RFA )
    University of Adelaide
    Open grant
  • 2015 - 2017
    Kidney energetics in the development of nephropathy in type 1 diabetes (DiaComp - NIH subaward administered by Augusta University)
    Augusta University
    Open grant
  • 2015
    Glucose transport in the diabetic kidney
    Diabetes Australia Research Trust
    Open grant
  • 2015 - 2019
    IL-22 as a Suppressor of Pancreatic Beta-Cell Stress and a Treatment for Diabetes
    NHMRC Project Grant
    Open grant
  • 2014 - 2016
    Urinary metabolic profiles as predictors of early diabetic nephropathy
    Kidney Health Australia
    Open grant
  • 2013 - 2014
    Identification of a novel target for the treatment of diabetic kidney disease
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Modern food processing as a contributor to type 1 diabetes
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    NHMRC Research Fellowship (SRF A): Delineating the role of advanced glycation in diabetes and nephropathy
    NHMRC Research Fellowship
    Open grant

Availability

Honorary Professor Josephine Forbes is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Honorary Professor Josephine Forbes's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au